This article was originally published in The Gray Sheet
Executive SummaryChief Operating Officer Arthur Collins, 45, joins board of directors, filling a vacancy created by the retirement of company founder Earl Bakken, the company announces at its annual shareholders meeting on Aug. 31. Bakken, 70, will assume the title of founder and director emeritus. Collins, who previously worked at Abbott Labs, joined Medtronic as executive VP and President of Medtronic International in 1992 and was promoted to COO in January 1994. Collins also will serve as interim president of the Cardiac Surgery business beginning Oct. 1 in anticipation of the retirement of Senior Vice President and President-Cardiac Surgery Willard Lewis, 63, on Oct. 31. Lewis joined Medtronic in 1989 as VP and general manager-cardiopulmonary after having served first as a consultant during Medtronic's acquisition of Johnson & Johnson Cardiovascular in 1987
You may also be interested in...
The last year of the run up to the full implementation of the MDR has been characterized by a flurry of new documents and measures, but industry is adamant that medtech is heading for a crisis that will impact industry and patients alike.
The Chinese government's plan to reduce tariffs it imposed on a slew of US exports is expected to have minimal impact on the overall medtech industry. See what Ralph Ives, AdvaMed's executive VP for global strategy, said about it here.